RUNX1 and breast cancer: All these pieces of evidence raise the hypothesis that Runx1 could function as a tumor suppressor in ER positive breast cancer; here we clearly demonstrate Runx1 has a direct role to prevent EMT in MCF7 ER+ breast cancer cells, and thus establishes Runx1 as a tumor suppressor.